Project Grant HT94252510480
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
This $853,312 federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) supports research at The Johns Hopkins University to detect pulmonary stromal premetastatic niches for early monitoring of post-surgery metastatic risk. The project aims to develop innovative techniques to identify early signs of metastatic cancer in lung tissue, which could enable earlier intervention and improved patient outcomes. The funding...
The Johns Hopkins University was awarded a $1,397,591 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support the development of a microfluidic assay to assess clinical utility for prognosis and precision medicine in breast cancer from May 1, 2022 to April 30, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $823,267.00 to The Johns Hopkins University to conduct research on "Mitochondrial Heteroplasmy as a Novel Risk Factor for Myelodysplastic Syndromes". The award, with a performance period from August 1, 2025 to July 31, 2028, will support advanced biomedical research focused on transforming healthcare for military service...
The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
The Johns Hopkins University was awarded a $1,170,746 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the polyaneuploid cancer cell state and its role in mediating multitherapy resistance in cancer. The three-year award, effective August 15, 2022 through August 14, 2025, will support research into transforming healthcare for service members and the public through innovative biomedical...
This $1,552,867 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by The Johns Hopkins University on the early detection of endometrial carcinoma through cell enrichment and flow cytometry. This grant aims to develop innovative approaches to improve the diagnosis and treatment of endometrial cancer, a condition highly relevant to military personnel and the broader public. The...
This federal Project Grant award of $360,413.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University focused on early hepatic dissemination of pancreatic cancer. The research aims to evaluate the efficacy of systemic chemotherapy-enhanced alpha-particle radiotherapy as a treatment approach. The award has a performance period from November 1, 2024 to October 31, 2027. As a leading academic...
This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...